Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
117 Psychotropics
1179 Others
D01176 Blonanserin (JAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
D01176 Blonanserin
DG03200 Antipsychotic agent
DG03064 Atypical antipsychotic
D01176 Blonanserin
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D01176 Blonanserin
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D01176 Blonanserin (JAN/INN) <JP>
DRD3
D01176 Blonanserin (JAN/INN) <JP>
Serotonin
HTR2A
D01176 Blonanserin (JAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01176
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01176
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01176